A carregar...

Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis

BACKGROUND: Treatment with recombinant human erythropoietin (rHuEPO) in dialysis patients has been shown to be highly effective in terms of correcting anaemia and improving quality of life. There is debate concerning the benefits of rHuEPO use in predialysis patients which may accelerate the deterio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Cody, June D, Hodson, Elisabeth M
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2016
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7144724/
https://ncbi.nlm.nih.gov/pubmed/26790135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003266.pub3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!